Viewing Study NCT06790420


Ignite Creation Date: 2025-12-25 @ 4:13 AM
Ignite Modification Date: 2026-05-09 @ 10:12 PM
Study NCT ID: NCT06790420
Status: COMPLETED
Last Update Posted: 2025-05-31
First Post: 2025-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lymphoma View
None Rituximab View
None Infection View